Novel drug-discovery approach lands big backers
UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases.
Source: medcitynews.com
Scott Biller News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Scott Biller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Scott Biller Today - Breaking & Trending Today
OMass Therapeutics Raises $100 Million in Series B
PRESS RELEASE OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases Financing led by new...
Source: globenewswire.com
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Sanofi-Backed OMass Therapeutics Rakes in $100M to Drug the "Undruggable"
Oxford, UK-based OMass Therapeutics closed on a $100 million Series B financing round. The round was led by new investors GV (formerly Google Ventures), Northpond Ventures and Sanofi Ventures. Three existing investors also participated: Syncona, Oxford Science Enterprise and Oxford University.
Source: biospace.com
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com